Novel antisense drug shows promise in slowing fatty liver disease
A first-in-class clinical trial suggests a novel treatment measurably slowed progression of non-alcoholic fatty liver disease to its more progressive and deadly form.
from Diet and Weight Loss News -- ScienceDaily https://ift.tt/2Bb8Ozx
No comments:
Post a Comment